CFR pharma expands global ambitions with Adcock bid

06:43 EDT 2 Aug 2013 | GaBI online

Chile-based CFR Pharmaceuticals (CFR) has plans to become a global drugmaker. In its latest efforts it has made a US$1.3 billion cash-and-share offer for South Africa’s second-largest generics drugmaker Adcock Ingram (Adcock).

Original Article: CFR pharma expands global ambitions with Adcock bid

NEXT ARTICLE

More From BioPortfolio on "CFR pharma expands global ambitions with Adcock bid"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story